![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 12, 7088-7093, March 20, 1998
,
,
, and
From the Previous reports have indicated that
benzothiophenes exhibit broad anti-inflammatory properties and inhibit
human immunodeficiency virus-type 1 (HIV-1) replication. We show that
the immunosuppressant cyclosporin A (CsA) and
benzothiophene-2-carboxamide, 5-methoxy-3-(1-methyl ethoxy)-1-oxide (PD
144795) block the induction of p53 and NF-
Department of Physiology and Biophysics and
Ireland Cancer Center, CWRU School of Medicine, Cleveland, Ohio 44106, the ¶ Department of Biochemistry, University of Seville School of
Medicine, 41009 Seville, Spain, the
Lineberger Comprehensive
Cancer Center and Department of Biology, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, and the
** Departments of Immunopathology and Molecular Biology, Parke-Davis
Pharmaceutical Research, Division of Warner-Lambert Co.,
Ann Arbor, Michigan 48105
B binding to the HIV-1
long terminal repeat (LTR) by the T cell receptor activator
phytohemagglutinin. CsA and PD 144795 also inhibit the induction by
phytohemagglutinin of the transcription mediated by an HIV-1 LTR
fragment containing the p53 and NF-
B sites. These effects of PD
144795 on HIV-1 transcription correlate with its ability to inhibit the
phosphatase activity of calcineurin and are similar to those previously
described for CsA. Moreover, a constitutive active form of calcineurin
is able to induce expression from the HIV-1 LTR in a p53- and
NF-
B-dependent manner and PD 144795 is able to block
this induction. These results demonstrate that the DNA binding of p53
to the HIV-1 LTR can be modulated by calcineurin and provide a
framework to understand the anti-HIV properties of benzothiophene
derivatives.
This article has been cited by other articles:
![]() |
R. El Bekay, G. Alba, M E. Reyes, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Ramos, J. Olivan, E. Pintado, et al. Rac2 GTPase activation by angiotensin II is modulated by Ca2+/calcineurin and mitogen-activated protein kinases in human neutrophils J. Mol. Endocrinol., November 1, 2007; 39(5): 351 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vega, P. Chacon, G. Alba, R. El Bekay, J. Monteseirin, J. Martin-Nieto, and F. Sobrino Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils J. Leukoc. Biol., July 1, 2006; 80(1): 152 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rivera and S. A. Maxwell The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway J. Biol. Chem., August 12, 2005; 280(32): 29346 - 29354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Perfettini, T. Roumier, M. Castedo, N. Larochette, P. Boya, B. Raynal, V. Lazar, F. Ciccosanti, R. Nardacci, J. Penninger, et al. NF-{kappa}B and p53 Are the Dominant Apoptosis-inducing Transcription Factors Elicited by the HIV-1 Envelope J. Exp. Med., March 1, 2004; 199(5): 629 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baumgrass, M. Weiwad, F. Erdmann, J. O. Liu, D. Wunderlich, S. Grabley, and G. Fischer Reversible Inhibition of Calcineurin by the Polyphenolic Aldehyde Gossypol J. Biol. Chem., December 14, 2001; 276(51): 47914 - 47921. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rusnak and P. Mertz Calcineurin: Form and Function Physiol Rev, October 1, 2000; 80(4): 1483 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Swoap, R. B. Hunter, E. J. Stevenson, H. M. Felton, N. V. Kansagra, J. M. Lang, K. A. Esser, and S. C. Kandarian The calcineurin-NFAT pathway and muscle fiber-type gene expression Am J Physiol Cell Physiol, October 1, 2000; 279(4): C915 - C924. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Eto, K. Yonekura, M. Sonoda, N. Arai, M. Sata, S. Sugiura, K. Takenaka, A. Gualberto, M. L. Hixon, M. W. Wagner, et al. Calcineurin Is Activated in Rat Hearts With Physiological Left Ventricular Hypertrophy Induced by Voluntary Exercise Training Circulation, May 9, 2000; 101(18): 2134 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Makino, M. Azuma, S.-I. Wakamatsu, Y. Suruga, S. Izumo, M. M. Yokoyama, and M. Baba Marked Suppression of T Cells by a Benzothiophene Derivative in Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Clin. Vaccine Immunol., May 1, 1999; 6(3): 316 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carballo, G. Marquez, M. Conde, J. Martin-Nieto, J. Monteseirin, J. Conde, E. Pintado, and F. Sobrino Characterization of Calcineurin in Human Neutrophils. INHIBITORY EFFECT OF HYDROGEN PEROXIDE ON ITS ENZYME ACTIVITY AND ON NF-kappa B DNA BINDING J. Biol. Chem., January 1, 1999; 274(1): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hixon, A. I. Flores, M. W. Wagner, and A. Gualberto Ectopic Expression of cdc2/cdc28 Kinase Subunit Homo sapiens 1 Uncouples Cyclin B Metabolism from the Mitotic Spindle Cell Cycle Checkpoint Mol. Cell. Biol., November 1, 1998; 18(11): 6224 - 6237. [Abstract] [Full Text] |
||||
![]() |
M. A. Sussman, H. W. Lim, N. Gude, T. Taigen, E. N. Olson, J. Robbins, M. C. Colbert, A. Gualberto, D. F. Wieczorek, and J. D. Molkentin Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition Science, September 11, 1998; 281(5383): 1690 - 1693. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |